OpenAI 2026 hackathon

IntakeOnce

Tell it once. Verify every field. IntakeOnce turns a patient’s own words into evidence-linked intake answers, then shares only what they approve and the clinic requested.

Solo project by Emil Jivishov · 1 likes · 0 comments

Archive position — measured, not model output

1 like on Devpost

506 of the 7,856 archived projects have more likes, and 1,758 share exactly 1 — so this project's #1,234 place in the like-ranked listing is a tie-break inside that group, not a ranking.

Projects (log scale)

1
10
100
1k
10k
05,592
11,758
2285
3–4132
5–975
10+14

Likes on Devpost. ▲ marks this project's group.

Show the figures
LikesProjectsShare of archive
05,59271.2%
11,75822.4%
22853.6%
3–41321.7%
5–9751.0%
10+140.2%
Devpost like counts for all 7,856 archived projects, captured when this archive was built.

Executive Summary

What the company appears to be

IntakeOnce is a self-reported prototype product built by one individual (Emil Jivishov) for the OpenAI 2026 hackathon. It is described as an AI-powered intake system that allows patients to provide information in their own words, with GPT-5.6 proposing structured answers linked to evidence from the patient's input. The system enforces patient control over what gets shared and ensures only requested fields are included in a FHIR R4 QuestionnaireResponse.

What changed

This is a fictional-data prototype built during a hackathon. It does not represent a live product or service, nor does it claim to integrate with EHRs or medical systems. The author states that this is a demonstration of workflow and trust boundaries, not a production-ready solution.

The single most important open question

Is there any evidence that the author intends to build a commercial version of IntakeOnce beyond the prototype? If so, what is the path to traction, revenue or customer adoption?

Note: This analysis is based solely on the self-reported description provided by the author. No external verification, funding history, headcount, customers or revenue data are available.

Back to contents

What The Product Actually Is

The description states that IntakeOnce:

  • Turns a patient’s own words into evidence-linked intake answers.
  • Uses GPT-5.6 to propose structured answers from patient input (typed or voice).
  • Requires patient review and approval of each proposed answer before sharing.
  • Only shares information that is both requested by the clinic and approved by the patient.
  • Generates FHIR R4 QuestionnaireResponse for simulated provider inbox.
  • Operates on fictional data only, with no EHR integration or clinical chart writing.
  • Uses Next.js, React, TypeScript, Zod, OpenAI APIs (GPT-5.6, Realtime API), and Codex.

Inference: The system is a proof-of-concept for a patient-controlled intake workflow using AI, focused on trust and transparency in data sharing.

Back to contents

Positioning & Claim Evolution

The author states:

  • “Tell it once. Verify every field.” — a tagline suggesting a focus on reducing redundancy and increasing accuracy.
  • “I built IntakeOnce around a simple principle: the model may propose, but the patient decides.”
  • The system is positioned as a way to improve trust in medical intake by giving patients control over their data.

Inference: The positioning is centered on patient agency, data integrity, and trust in AI-assisted workflows. It does not claim to be a replacement for existing intake systems or EHRs, but rather a new model of how patient input can be processed with transparency.

Back to contents

Target Customer & ICP

The description states:

  • The system is designed for patients and clinics.
  • Patients provide information in English or Spanish via typing or voice.
  • Clinics request specific fields to be filled.
  • The system simulates a provider inbox with FHIR output.

Inference: The primary customer segments are patients and healthcare providers (clinics). The ICP appears to be healthcare organizations seeking better patient data quality and trust, especially in intake workflows.

Not evidenced: No specific clinic types, use cases or target market size are mentioned.

Back to contents

Business Model & Pricing Evidence

The description states:

  • This is a prototype for a hackathon.
  • It does not claim to have a business model or pricing structure.
  • The author mentions future steps include “authentication, tenant authorization, durable encrypted storage, formal security and privacy review, retention controls, validated interoperability services, and authorized EHR integration.”

Inference: No commercial model is currently evident. The author implies that the next step would involve monetization through healthcare system integrations or SaaS offerings.

Back to contents

Technical & Delivery Signals

The description states:

  • Built with Next.js, React, TypeScript, Zod, OpenAI APIs (GPT-5.6, Realtime API), and Codex.
  • Uses deterministic code to validate schema, reject unauthorized fields, verify evidence quotes, and generate FHIR.
  • Supports voice input via Whisper and GPT-Realtime APIs.
  • Includes browser-based review and a temporary key dialog for API access.
  • Demonstrates 18 synthetic safety scenarios.

Inference: The technical stack suggests a modern web application with AI integration and strong validation logic. The use of deterministic code to enforce policy is a notable signal of intentional design for trust and compliance.

Back to contents

Traction & Maturity Signals

The description states:

  • This is a fictional-data prototype.
  • It does not claim to have customers, revenue, or adoption.
  • The author notes it runs on Fly.io and includes evaluation fixtures.
  • No mention of user testing, pilot programs, or real-world usage.

Inference: There is no evidence of traction or maturity beyond the hackathon prototype. No data on users, performance, or product-market fit is provided.

Back to contents

Competitive Context

The description does not mention any competitors or existing solutions in the space.

Not evidenced: No competitive landscape, market positioning, or differentiation from other intake or AI tools is described.

Back to contents

Key Risks & Red Flags

  • No commercial traction or revenue: The product is a prototype with no evidence of monetization.
  • Unverified claims: The author states that this is a fictional-data system and does not integrate with EHRs or perform clinical actions.
  • Single-person team: The entire project was built by one individual, raising questions about scalability and long-term maintenance.
  • No customer feedback or validation: There is no mention of user testing or real-world input from patients or clinics.
  • Unproven path to production: While the author outlines next steps, there is no evidence that these have been executed or validated.

Back to contents

Diligence Questions To Ask The Founders

  1. What is the intended path to commercialization beyond this prototype?
  2. Has the founder tested the workflow with actual patients or clinics?
  3. Are there any plans to integrate with real EHR systems or healthcare data standards?
  4. What are the key assumptions about patient behavior and clinic workflows that underpin this product?
  5. How does the founder plan to address security, privacy, and compliance requirements for a production version?
  6. Is there any interest from healthcare providers or institutions in piloting this system?

Back to contents

Investment/Partnership Verdict

The description states:

  • This is a hackathon prototype.
  • No evidence of revenue, customers, or traction exists.
  • The author has not yet built a commercial product.

Inference: At this stage, there is no basis for investment or partnership. The project shows strong design thinking and technical execution but lacks any commercial signal. It may be an interesting idea to explore further, but it is not ready for due diligence at the investment or partnership level.

Confidence Level: Low — based on self-reported prototype with no external validation or traction evidence.

Back to contents

Source

Submitted to the OpenAI 2026 hackathon on Devpost. Project home on DevPost.

The analysis above was generated by a language model from the project's own one-line description. It is not independent research and contains no verified traction, revenue or customer data.